Trial Produces Practice-Changing Findings for Some Children, Young Adults with Leukemia

This NCI-funded Children’s Oncology Group trial tested the addition of nelarabine (Arranon) to standard treatment for children and young adults with T-cell acute lymphoblastic leukemia (T-ALL).

Cancer Currents: An NCI Cancer Research Blog